# Timing of Corticosteroids in COVID-19, II. Post COVID-19 Follow-up

> **NCT04530409** · PHASE4 · UNKNOWN · sponsor: **ClinAmygate** · enrollment: 752 (actual)

## Conditions studied

- Covid19
- Corticosteroids

## Interventions

- **DRUG:** Early-Corticosteroids

## Key facts

- **NCT ID:** NCT04530409
- **Lead sponsor:** ClinAmygate
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-20
- **Primary completion:** 2021-11-01
- **Final completion:** 2023-10-15
- **Target enrollment:** 752 (ACTUAL)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04530409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04530409, "Timing of Corticosteroids in COVID-19, II. Post COVID-19 Follow-up". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04530409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*